Insider trading activities (stock purchases, sales, and option exercises)
reported by insiders of Leap Therapeutics, Inc. (LPTX)
since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Leap Therapeutics, Inc. since year 2005.
Table 2 shows the detailed insider transactions of Leap Therapeutics, Inc. since 2005.
The reporting company's ticker symbol is LPTX. The reporting company's CIK number is 1509745.
The total value of stock buying since 2005 is $29,746,092.
The total value of stock sales since 2005 is $0.
The total value of stock option exercises since 2005 is $0.
|Trading Period||Insider Buying||Insider Sales||Option Exercises|
|Trade Date||Insider Name||Trade Type||Shares||Price ($)||Value ($)|
|2019-02-05||Healthcare Partners Ix, Llc (10% Owner)||Buy||571,428||1.75||999,999|
|2019-02-05||Onsi Douglas E (CFO, GC, Treasurer & Secretary)||Buy||571,428||1.75||999,999|
|2019-02-05||Lawlor Augustine (Chief Operating Officer)||Buy||571,428||1.75||999,999|
|2019-02-05||Mirabelli Christopher (CEO, President, Chairman)||Buy||571,428||1.75||999,999|
|2017-11-14||Healthcare Partners Ix, Llc (10% Owner)||Buy||1,057,769||6.08||6,436,524|
|2017-11-14||Onsi Douglas E (CFO, GC, Treasurer & Secretary)||Buy||1,057,769||6.08||6,436,524|
|2017-11-14||Lawlor Augustine (Chief Operating Officer)||Buy||1,057,769||6.08||6,436,524|
|2017-11-14||Mirabelli Christopher (CEO, President, COB)||Buy||1,057,769||6.08||6,436,524|
Insider trading activities including stock purchases, stock sales, and option exercises of LPTX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Leap Therapeutics, Inc. (symbol LPTX, CIK number 1509745) see the Securities and Exchange Commission (SEC) website.